Sevista 30 MG Tablet 15

Torrent Pharmaceuticals Ltd.

  • STRIP of 10 Units
  • STRIP of 15 Units

MRP ₹126.5

₹103.73

₹8.43/Units

18% off
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

Login to view saved addresses

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store Below 30o C

compositionComposition
Ormeloxifene (30 Mg)

About Sevista 30 MG Tablet 15

Sevista 30 Tablet is a medicine used to prevent pregnancy and control abnormal vaginal bleeding. It is an oral contraceptive pill that has multiple uses, including being an effective method of contraception to prevent unintended pregnancy, perimenopausal bleeding and dysfunctional uterine bleeding.

Sevista 30 Tablet provides reliable and safe contraception when used correctly. Moreover, it offers the convenience of being taken only once a week, making it easier for women to use. Some common side effects of taking Sevista 30 Tablet are headache, nausea and breast tenderness.

The dosage and frequency of Sevista 30 Tablet should be determined by your doctor, so it's important to consult them for guidance. Additionally, please follow any precautions or guidelines provided by your healthcare professional to ensure the safe and effective use of this medicine.

Last Updated On 25 Aug. 2023 | 12:45PM (IST)

Certified Content

Written by

Bhavya Mehta
Bhavya Mehta
Scientific & Medical Writer | 3 years

M.Sc. Biological Sciences

Reviewed by

Dr. Lakshmi Vaswani
Dr. Lakshmi Vaswani
Medical Content Consultant | 16 years

MBBS, Dip.Pathology, MBA (Healthcare Services)

Check out Editorial Policy

Manufacturer details

Torrent House, Off. Ashram Road, Ahmedabad - 380009, Gujarat, India

Country of origin: INDIA

References

  • Ormeloxifene: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB13310
  • BS, D.Nanda, S.K.,(2013).The Role of Sevista in the Management of Dysfunctional Uterine Bleeding,J Clin of Diagn Res. 7(1), 132-134. 
  • Pati, T., Chanania, K., Marandi, S., & Hansa, J. (2017). Ormeloxifene - Looking beyond contraception. Journal of mid-life health, 8(1), 17–20. https://doi.org/10.4103/jmh.JMH_71_16
  • “UNII - 44AXY5VE90.” Precision.fda.gov, precision https://precision.fda.gov/uniisearch/srs/unii/44AXY5VE90
Was this product description useful?
100 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.

playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.4.14

copyright2024 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner